CY1110706T1 - Αντιβακτηριδιακα παραγωγα κινολινης - Google Patents

Αντιβακτηριδιακα παραγωγα κινολινης

Info

Publication number
CY1110706T1
CY1110706T1 CY20101100708T CY101100708T CY1110706T1 CY 1110706 T1 CY1110706 T1 CY 1110706T1 CY 20101100708 T CY20101100708 T CY 20101100708T CY 101100708 T CY101100708 T CY 101100708T CY 1110706 T1 CY1110706 T1 CY 1110706T1
Authority
CY
Cyprus
Prior art keywords
compounds
preparation
pharmaceutically acceptable
treatment
kinolin
Prior art date
Application number
CY20101100708T
Other languages
English (en)
Inventor
Jérôme Emile Georges Guillemont
Magali Madeleine Simone Motte
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1110706T1 publication Critical patent/CY1110706T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε νέα παράγωγα υποκατεστημένης κινολίνης σύμφωνα με το γενικό τύπο (la) ή τον τύπο (lb): περιλαμβανομένων οποιωνδήποτε στερεοχημικά ισομερών μορφών αυτών, ενός φαρμακευτικά αποδεκτού άλατος αυτών, μίας μορφής Ν-οξειδίου αυτών ή ενός επιδιαλυτωμένου άλατος αυτών. Οι ενώσεις που αξιώνονται είναι χρήσιμες για τη θεραπεία μίας βακτηριδιακής μόλυνσης. Επίσης αξιώνεται μία σύνθεση που περιλαμβάνει ένα φαρμακευτικά αποδεκτό φορέα και, ως ενεργό συστατικό, μία θεραπευτικά αποτελεσματική ποσότητα των αξιωνώμενων ενώσεων, η χρήση των αξιωνώμενων ενώσεων ή σύνθετων ιόντων για την παρασκευή ενός φαρμακευτικού μέσου για τη θεραπεία μίας βακτηριδιακής μόλυνσης και μία διεργασία για την παρασκευή των αξιωνώμενων ενώσεων.
CY20101100708T 2006-12-06 2010-07-28 Αντιβακτηριδιακα παραγωγα κινολινης CY1110706T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125521 2006-12-06
EP07847813A EP2086941B1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
CY1110706T1 true CY1110706T1 (el) 2015-06-10

Family

ID=37944337

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100708T CY1110706T1 (el) 2006-12-06 2010-07-28 Αντιβακτηριδιακα παραγωγα κινολινης

Country Status (30)

Country Link
US (1) US7998979B2 (el)
EP (1) EP2086941B1 (el)
JP (1) JP5356245B2 (el)
KR (1) KR101490221B1 (el)
CN (1) CN101541752B (el)
AR (1) AR064150A1 (el)
AT (1) ATE465994T1 (el)
AU (1) AU2007328889B2 (el)
BR (1) BRPI0720251B8 (el)
CA (1) CA2668520C (el)
CL (1) CL2007003516A1 (el)
CY (1) CY1110706T1 (el)
DE (1) DE602007006231D1 (el)
DK (1) DK2086941T3 (el)
ES (1) ES2344535T3 (el)
HK (1) HK1137428A1 (el)
HR (1) HRP20100384T1 (el)
IL (1) IL199081A (el)
JO (1) JO2685B1 (el)
ME (1) ME01073B (el)
MX (1) MX2009005980A (el)
NO (1) NO341995B1 (el)
NZ (1) NZ576673A (el)
PL (1) PL2086941T3 (el)
PT (1) PT2086941E (el)
RS (1) RS51390B (el)
RU (1) RU2446159C2 (el)
SI (1) SI2086941T1 (el)
TW (1) TWI412364B (el)
WO (1) WO2008068269A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA038350B1 (ru) 2012-04-27 2021-08-12 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
CN104650054B (zh) * 2013-11-25 2019-09-13 重庆医药工业研究院有限责任公司 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033389B2 (ja) * 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
CA2270123A1 (en) 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
MXPA04000968A (es) * 2001-07-31 2005-02-17 Univ Wayne State Derivados de quinolina y uso de los mismos como agentes antitumor.
PL222801B1 (pl) 2002-07-25 2016-09-30 Janssen Pharmaceutica Nv Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
AP2188A (en) 2004-01-23 2010-12-14 Janssen Pharmaceutica Nv Substituted quinolines and their use as mycobacterial inhibitors.
PT1711181E (pt) 2004-01-23 2009-12-29 Janssen Pharmaceutica Nv Derivados quinolina e sua utilização como inibidores micobacterianos
AU2005210036B2 (en) * 2004-01-29 2010-12-23 Janssen Pharmaceutica N.V. Quinoline derivatives for use as mycobacterial inhibitors
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
DK1797115T3 (en) 2004-09-28 2017-10-02 Janssen Pharmaceutica Nv BACTERIAL ATP SYNTHASE BINDING DOMAIN.

Also Published As

Publication number Publication date
ATE465994T1 (de) 2010-05-15
EP2086941A1 (en) 2009-08-12
AU2007328889A1 (en) 2008-06-12
NO341995B1 (no) 2018-03-12
JP2010511670A (ja) 2010-04-15
AU2007328889B2 (en) 2012-12-06
BRPI0720251B1 (pt) 2020-10-06
CN101541752A (zh) 2009-09-23
WO2008068269A1 (en) 2008-06-12
DE602007006231D1 (de) 2010-06-10
JO2685B1 (en) 2013-03-03
TWI412364B (zh) 2013-10-21
MX2009005980A (es) 2009-06-16
EP2086941B1 (en) 2010-04-28
PT2086941E (pt) 2010-07-14
KR101490221B1 (ko) 2015-02-05
KR20090087071A (ko) 2009-08-14
IL199081A (en) 2013-08-29
NZ576673A (en) 2011-09-30
AR064150A1 (es) 2009-03-18
RU2009125525A (ru) 2011-01-20
RU2446159C2 (ru) 2012-03-27
SI2086941T1 (sl) 2010-08-31
DK2086941T3 (da) 2010-08-09
TW200845987A (en) 2008-12-01
US7998979B2 (en) 2011-08-16
CL2007003516A1 (es) 2008-07-11
ME01073B (me) 2012-10-20
ES2344535T3 (es) 2010-08-30
NO20092540L (no) 2009-09-07
CA2668520A1 (en) 2008-06-12
CA2668520C (en) 2016-01-26
BRPI0720251A2 (pt) 2014-01-07
JP5356245B2 (ja) 2013-12-04
CN101541752B (zh) 2013-07-17
HRP20100384T1 (hr) 2010-08-31
US20100063061A1 (en) 2010-03-11
HK1137428A1 (en) 2010-07-30
PL2086941T3 (pl) 2010-10-29
BRPI0720251B8 (pt) 2021-05-25
RS51390B (en) 2011-02-28

Similar Documents

Publication Publication Date Title
CY1117766T1 (el) Αντιβακτηριδιακα παραγωγα κινολινης
CY1111188T1 (el) Αντιβακτηριακα παραγωγα κινολινης
CY1110388T1 (el) Χρηση υποκατεστημενων παραγωγων κουινολινης για τη θεραπευτικη αντιμετωπιση μυκοβακτηριακων ασθενειων ανθεκτικων σε φαρμακα
CY1117247T1 (el) Αντιβακτηριακα παραγωγα κινολινης
CY1112230T1 (el) Αντιβακτηριακα παραγωγα κινολινης
CY1114384T1 (el) Αντιβακτηριακα παραγωγα κινολινης
CY1118515T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
CY1110706T1 (el) Αντιβακτηριδιακα παραγωγα κινολινης
EA201491982A1 (ru) Антибактериальные хинолиновые производные
CY1112027T1 (el) Αντιβακτηριακα παραγωγα κινολινης
EA201491971A1 (ru) Антибактериальные хинолиновые производные